Selective Serotonin Reuptake Inhibitors (SSRIs) Information
This class of drugs is used to treat depression, anxiety, and other mood disorders.
Marketed under various brand and generic drug names
Generic name | Found in Brand name(s) |
---|---|
Citalopram | Celexa |
Escitalopram | Lexapro |
Fluoxetine | Prozac, Sarafem, Symbyax |
Fluvoxamine | Luvox, Luvox CR |
Paroxetine | Paxil, Paxil CR, Pexeva |
Sertraline | Zoloft |
Vilazodone | Viibryd |
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program, using the contact information at the bottom of this page.
Related Information
- Citalopram (marketed as Celexa) Information
- Escitalopram (marketed as Lexapro) Information
- Fluoxetine (marketed as Prozac) Information
- Fluvoxamine Maleate Information
- Paroxetine hydrochloride (marketed as Paxil) Information
- Sertraline (marketed as Zoloft) Information
Additional Information
- FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies
- FDA Drug Safety Podcast for Healthcare Professionals: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies
- Comunicado de la FDA sobre la seguridad de los medicamentos: El uso de antidepresivos con inhibidor selectivo de recaptación de serotonina (SSRI por sus siglas en inglés) durante el embarazo y reportes de afecciones cardiacas y pulmonares poco comunes en recién nacidos
- Antidepressant Use in Children, Adolescents, and Adults
- Public Health Advisory: Treatment Challenges of Depression in Pregnancy and the Possibility of Persistent Pulmonary Hypertension in Newborns
- Public Health Advisory: Combined Use of 5-Hydroxytryptamine Receptor Agonists (Triptans), Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) May Result in Life-threatening Serotonin Syndrome